Skip to main content

FCPS Cardiology TOACS - ECG, Echocardiography, Cath, CMR, CT, CXR, EP Tracings, Nuclear Scans

Attempt this exam to know your Score to get an idea of your fcps part 2 toacs preparation:


Welcome to cardiology toacs mock exam , there will be 40 stations, time for each station is usually 3 mins in the exam but in this video it will be, 1 min. you can pause the video if you need more time.

 Answer key is also shown in the video after 40 stations.

For More TOACS stuff <<Click here>>


In this comprehensive TOACS (Task Oriented Assessment of Clinical Skills) session, the candidate is taken through multiple diagnostic modalities in cardiology: surface ECG, chest-X-ray (CXR), echocardiography (Echo), cardiac catheterisation/angiography (Cath), cardiac CT, cardiac MRI (CMR), electrophysiology (EP) tracings, and nuclear scans (e.g., SPECT stress test). The aim is to test the ability of the trainee to interpret images/recordings, link them to the clinical scenario, derive diagnoses, and suggest appropriate next steps (management/investigations). The video shows multiple “stations” where you are given data (an ECG, a CXR, a CTA, etc), asked questions like “What is the abnormality?”, “What is the likely diagnosis?”, “What is the next best step?”, and “What is the management plan?”. The modalities emphasised include:


ECG: rhythm abnormalities, ST-T changes, conduction defects, hypertrophy patterns


CXR: cardiomegaly, pulmonary congestion, vascular redistribution, pleural effusions


Echocardiography: chamber sizes, valve lesions, ejection fraction, pericardial effusion, Doppler flows


Cardiac Cath / Angiography: coronary anatomy, lesions, intervention options


Cardiac CT / CMR: structural anomalies, functional assessment, tissue characterisation


EP tracings: arrhythmia mechanism, accessory pathways, ablation strategy


Nuclear scans / Stress imaging: perfusion defects, viability, ischaemia vs scar



The video emphasises integrating all this into one coherent clinical picture — not just recognising the finding, but relating it to the patient’s symptoms, risk factors, and what the next appropriate step is (for example, “If you see a large fixed perfusion defect on SPECT stress scan, then viability is low and CABG may not help; consider medical therapy,” or “If the CMR shows late gadolinium enhancement in a non-ischaemic pattern, suspect myocarditis or cardiomyopathy”).


The video thus serves as a mock assessment for the TOACS format job: you have to be quick, accurate, confident in interpretation, and ready to justify reasoning. For exam preparation it’s excellent because it covers exactly the kinds of stations you will face, emphasising pattern recognition + decision making.



---


Commonly Asked Questions for FCPS Cardiology TOACS & Sample Answers


Here are some frequently asked types of questions with model answers you can use in your blog.


Q1. On ECG you see broad QRS with delta wave and short PR — what is the diagnosis? What is the next step?

Answer: The ECG features (short PR interval, delta wave, wide QRS) point to pre-excitation via an accessory pathway, consistent with Wolff‑Parkinson‑White syndrome. The next step is to assess symptoms (syncope, palpitations), look for arrhythmia history (AVRT, atrial fibrillation). In a symptomatic patient or high-risk pathway, refer for EP study and consider catheter ablation. In asymptomatic low-risk patients, manage conservatively but counsel about signs of life-threatening arrhythmia.


Q2. You are shown a CXR with enlarged cardiac silhouette, pulmonary venous congestion and pleural effusion in a patient with dyspnoea. Which diagnosis and what investigation next?

Answer: The radiographic appearance suggests left ventricular failure leading to cardiomegaly, pulmonary venous hypertension and pleural effusion. In the context of dyspnoea, one should suspect chronic heart failure (e.g., dilated cardiomyopathy) or acute decompensation. The next investigation is echocardiography to assess LV size, function (ejection fraction), valve lesions, and to look for pericardial effusion or other structural causes. Additionally, check BNP/NT-proBNP, renal function and rule out acute coronary syndrome.


Q3. On Echo you see severe mitral regurgitation with flail leaflet, left atrial enlargement and normal LV size. What is the likely cause and management?

Answer: A flail mitral leaflet with severe MR and left atrial enlargement but relatively preserved LV size suggests primary (degenerative) mitral valve disease (e.g., chordal rupture) rather than secondary (ventricular) MR. The likely cause is myxomatous degeneration leading to leaflet rupture. Management: symptomatic severe MR or evidence of LV dysfunction/enlargement or pulmonary hypertension warrants referral for mitral valve repair (if feasible) rather than replacement, ideally before irreversible LV damage. Medical therapy (afterload reduction, diuretics) is a bridge.


Q4. Cardiac CT in a patient shows anomalous origin of left coronary artery from the pulmonary artery (ALCAPA). What are the risks and treatment?

Answer: The anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) leads to coronary steal, myocardial ischaemia, LV dysfunction, mitral regurgitation, and sudden death. The risks are high for heart failure in infancy and sudden cardiac death if left untreated. The treatment is surgical correction of the coronary anatomy (reimplantation of LCA into the aorta or Takeuchi procedure) to restore normal coronary perfusion.


Q5. On CMR you see late gadolinium enhancement in a mid-wall pattern in a young male with heart failure symptoms. What does this suggest and how does it affect prognosis?

Answer: Mid-wall late gadolinium enhancement on CMR in a non-ischaemic distribution suggests a non-ischaemic cardiomyopathy (e.g., dilated cardiomyopathy with fibrosis). This is associated with worse prognosis: higher risk of ventricular arrhythmias, sudden cardiac death, and worse response to therapy. It may influence decisions about implantable cardioverter-defibrillator (ICD) placement and closer follow-up.


Q6. In a nuclear SPECT stress scan you find reversible perfusion defects in the anterior wall and fixed defects in the inferior wall. What is interpretation and management?

Answer: Reversible perfusion defects indicate inducible ischaemia (viable myocardium at risk) in the anterior wall, while fixed defects represent scar (non-viable) in the inferior wall. Management: The anterior wall ischaemia indicates benefit from revascularisation (PCI or CABG) depending on coronary anatomy, functional capacity and comorbidities. The scarred inferior wall indicates previous infarction; guide medical therapy and consider ICD if LV dysfunction meets criteria.


Q7. On EP tracing you see a narrow QRS tachycardia that terminates with adenosine and on post-termination you see a short PR and delta wave. What is going on?

Answer: The narrow QRS tachycardia terminating with adenosine suggests a supraventricular tachycardia (SVT) mechanism. The post-termination finding of a short PR interval and delta wave suggests underlying accessory pathway (WPW). The mechanism of tachycardia is likely atrioventricular reciprocating tachycardia (AVRT) using the accessory pathway. Management: acute termination (adenosine intravenous) is correct; long-term management includes EP study and ablation of the accessory pathway to prevent future episodes and risk of rapid atrial fibrillation.


Q8. What are the indications for using CMR over echocardiography?

Answer: While echocardiography is first-line for structural assessment due to accessibility, CMR has advantages including superior image quality for complex anatomy, accurate quantification of volumes and ejection fraction, tissue characterisation (e.g., fibrosis via late gadolinium enhancement), assessment of myocarditis, cardiomyopathies, infiltrative diseases (e.g., amyloidosis, sarcoidosis) and viability. For patients in whom echo windows are poor or additional tissue information is needed, CMR is the modality of choice.


More Concepts commonly asked:

---

πŸ«€ FCPS Cardiology TOACS – Common Questions & Answers


πŸ”Ή ECG Interpretation Stations


Q1. A 12-lead ECG shows irregularly irregular rhythm, no distinct P waves, variable R-R intervals. What is the diagnosis and initial management?

A1. This is Atrial Fibrillation (AF). Initial management depends on stability:


Unstable (hypotension, chest pain, pulmonary edema): Immediate synchronized cardioversion.


Stable: Rate control (Ξ²-blocker, diltiazem, digoxin), anticoagulation assessment using CHA₂DS₂-VASc score, and plan for rhythm control if indicated.




---


Q2. ST-segment elevation in II, III, aVF with reciprocal depression in I, aVL — diagnosis and management?

A2. Inferior wall STEMI due to right coronary artery occlusion.


Give aspirin + clopidogrel (or ticagrelor), heparin, high-dose statin, and immediate reperfusion (primary PCI preferred; if unavailable, thrombolysis).


Check for RV infarction (do right-sided leads). Avoid nitrates if RV involvement suspected.




---


Q3. ECG shows wide-complex tachycardia at 160 bpm with AV dissociation and capture beats. Diagnosis and treatment?

A3. Sustained Monomorphic Ventricular Tachycardia (VT).


Stable: IV amiodarone or procainamide.


Unstable: Immediate synchronized cardioversion.


Long-term: Identify cause (ischemia, cardiomyopathy); consider ICD implantation.




---


Q4. Prolonged QT interval followed by torsades-de-pointes episodes — what are the causes and management?

A4. Causes: Drugs (antiarrhythmics, macrolides, antipsychotics), electrolyte abnormalities (↓K⁺, ↓Mg²⁺, ↓Ca²⁺), congenital long QT.

Management: IV magnesium sulfate, correction of electrolytes, stop offending drugs, pacing if recurrent.



---


Q5. ECG with deep Q waves in V1–V4 and persistent ST elevation months after MI — interpretation?

A5. Left Ventricular Aneurysm following anterior MI.

Confirm with echocardiography (akinetic/dyskinetic wall, possible thrombus). Treat with anticoagulation and consider surgery if heart failure or embolic risk.



---


πŸ”Ή Chest X-Ray (CXR) Stations


Q6. CXR shows boot-shaped heart and decreased pulmonary vascular markings in a child — diagnosis?

A6. Tetralogy of Fallot. The boot shape is due to right ventricular hypertrophy; decreased pulmonary markings reflect pulmonary stenosis.



---


Q7. CXR with “water-bottle-shaped” cardiac silhouette and clear lung fields — likely diagnosis?

A7. Pericardial Effusion. Confirm with echocardiography to assess effusion size and tamponade physiology.



---


Q8. CXR showing rib notching and figure-of-3 sign — what is the diagnosis?

A8. Coarctation of Aorta. Rib notching due to collateral intercostal circulation; figure-of-3 from pre- and post-stenotic aortic dilatation.



---


πŸ”Ή Echocardiography Stations


Q9. Echo shows concentric LV hypertrophy with small LV cavity and speckled myocardium. Diagnosis and next step?

A9. Suggestive of Restrictive Cardiomyopathy / Amyloidosis. Confirm with CMR (late gadolinium enhancement with diffuse subendocardial pattern). Treat underlying cause and manage heart failure with diuretics; avoid excessive preload reduction.



---


Q10. Echo shows severe AS (aortic stenosis) — mean gradient 60 mmHg, valve area 0.6 cm², EF 45%. Management?

A10. Severe symptomatic aortic stenosis → definitive treatment is surgical AVR or TAVR (if high surgical risk). Medical therapy is supportive only.



---


Q11. Echo shows large pericardial effusion with diastolic collapse of right atrium and ventricle. Diagnosis and management?

A11. Cardiac Tamponade. Immediate pericardiocentesis under echo guidance. Address underlying cause (infection, malignancy, uremia, etc.).



---


Q12. Echo shows LV apical ballooning with hypercontractile base in a woman after emotional stress. Diagnosis?

A12. Takotsubo (Stress) Cardiomyopathy. Often mimics MI but coronary angiography shows normal arteries. Supportive care; usually reversible in weeks.



---


πŸ”Ή Cardiac Catheterization / Angiography


Q13. Coronary angiogram shows left main stenosis >50%. What is the preferred management?

A13. CABG (Coronary Artery Bypass Grafting) is indicated for left main disease due to prognostic benefit.



---


Q14. Cath report shows FFR = 0.74 in mid-LAD lesion. What does it mean?

A14. FFR < 0.80 indicates functionally significant stenosis → revascularization (PCI or CABG) is warranted.



---


Q15. LV angiogram shows apical dyskinesia and basal hyperkinesia with normal coronaries. Diagnosis?

A15. Takotsubo Cardiomyopathy. Often triggered by emotional or physical stress. Manage supportively.



---


πŸ”Ή Cardiac CT / CMR


Q16. CMR shows diffuse subendocardial late gadolinium enhancement and thickened myocardium. What is the diagnosis?

A16. Cardiac Amyloidosis. Characteristic diffuse enhancement pattern and difficulty nulling myocardium signal.



---


Q17. Cardiac CT shows calcium score 1200 Agatston units. Interpretation?

A17. Very high coronary calcium burden → high risk for obstructive coronary disease; mandates aggressive risk factor control and further evaluation (stress test or CTA).



---


Q18. CMR shows transmural LGE in LAD territory — what does it indicate?

A18. Non-viable scar tissue post-infarction; revascularization unlikely to improve function in that segment.



---


πŸ”Ή EP (Electrophysiology) & Arrhythmias


Q19. EP tracing shows dual AV nodal pathways with echo beats. Diagnosis?

A19. AV Nodal Re-entrant Tachycardia (AVNRT). Slow-fast re-entry circuit; ablation of slow pathway is curative.



---


Q20. EP study shows inducible sustained VT post-MI. What’s the implication?

A20. High risk of sudden cardiac death. ICD implantation is indicated for secondary prevention.



---


Q21. Sinus pauses >3 seconds, alternating brady and tachy episodes on Holter — diagnosis and management?

A21. Tachy-Brady Syndrome (Sick Sinus Syndrome). Management: permanent pacemaker implantation if symptomatic.



---


πŸ”Ή Nuclear Cardiology / Stress Imaging


Q22. Stress thallium scan shows reversible inferolateral defect with normal rest image. Interpretation?

A22. Reversible ischemia in inferolateral wall — viable myocardium at risk → consider coronary angiography and revascularization.



---


Q23. PET scan shows preserved FDG uptake in hypoperfused segments. What does it mean?

A23. Viable but hibernating myocardium — likely to recover function after revascularization.



---


Q24. Nuclear perfusion scan shows fixed anterior defect with LV dilatation and low EF. Interpretation?

A24. Old anterior MI with scar and remodeling. Management includes optimal medical therapy for HFrEF and ICD consideration if EF < 35%.



---


πŸ”Ή Integrated Clinical Decision Questions


Q25. A patient presents with exertional dyspnoea, EF = 35%, QRS = 160 ms with LBBB morphology. Next best therapy?

A25. Cardiac Resynchronization Therapy (CRT) is indicated if symptomatic on GDMT, EF ≤ 35%, QRS ≥ 150 ms with LBBB pattern.



---


Q26. A patient with dilated cardiomyopathy and EF = 25% asks about prognosis. What key factors affect it?

A26. Prognosis depends on NYHA class, EF, QRS duration, presence of fibrosis on CMR, and response to GDMT. ICD/CRT improve survival if indicated.



---


Q27. After MI, patient develops hypotension, elevated JVP, and clear lungs. What should you suspect?

A27. Right Ventricular Infarction. Manage with volume loading, avoid nitrates, and treat underlying infarct (RCA occlusion).



---


Q28. A young athlete has syncope during exercise; ECG shows deep inverted T waves in V1–V3. Diagnosis and test to confirm?

A28. Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC). Confirm with CMR showing RV dilation and fibrofatty infiltration. Advise exercise restriction and consider ICD.



---


Q29. Post-valve surgery patient develops fever and new murmur. What is the investigation of choice?

A29. Transesophageal Echocardiography (TEE) — gold standard for detecting prosthetic valve endocarditis (vegetations, abscess).



---


Q30. Patient on pacemaker presents with dizziness and cannon A-waves. Likely diagnosis?

A30. Pacemaker-Mediated Tachycardia or AV Dyssynchrony. Check pacemaker settings, perform device interrogation, and reprogram if needed.



🩺 Keywords:


FCPS Cardiology TOACS preparation


FCPS Cardiology exam Pakistan


Cardiology TOACS questions and answers


ECG interpretation for FCPS


Echocardiography viva FCPS


Cardiac catheterization cases


CMR and cardiac MRI for FCPS


Cardiology OSCE Pakistan


Electrophysiology tracings TOACS


Nuclear cardiology questions


Cardiology case-based discussion


FCPS Cardiology viva practice


FCPS cardiology mock stations


FCPS exam cardiology pattern


Cardiology TOACS 2025


FCPS part 2 cardiology clinical exam


How to prepare for FCPS Cardiology


Common FCPS cardiology cases



Institutional Keywords (Pakistan Hospitals & Institutes):


NICVD Karachi cardiology training


AFIC Rawalpindi cardiology TOACS


Punjab Institute of Cardiology Lahore FCPS


Faisalabad Institute of Cardiology (FIC) FCPS


Rawalpindi Institute of Cardiology (RIC) FCPS


Ch. Pervaiz Elahi Institute of Cardiology Multan


Tabba Heart Institute Karachi


Shifa International Hospital Islamabad cardiology


Aga Khan University Hospital Karachi FCPS


Rehman Medical Institute Peshawar cardiology


Dow University Hospital cardiology


Bahawal Victoria Hospital Cardiology


Hayatabad Medical Complex cardiology


Armed Forces Institute of Cardiology Rawalpindi


National Institute of Cardiovascular Diseases (NICVD)



Supporting Keywords:


cardiology viva preparation


ECG cases Pakistan


echocardiography interpretation


cath lab cases Pakistan


cardiac imaging CT MRI FCPS


EP tracings and arrhythmias


nuclear cardiology scan examples


cardiology residents Pakistan


CPSP FCPS guidelines


Pakistan medical exams postgraduate


FCPS tips and resources




---


πŸ”– Hashtags for Social Media & YouTube


Use a mix of general, exam-specific, and Pakistan-based hashtags to reach the right audience:


πŸŽ“ Exam-Focused


#FCPScardiology

#TOACSpreparation

#CardiologyTOACS

#FCPSPakistan

#FCPSPart2

#CardiologyExam

#FCPSViva

#TOACSExam

#FCPSJourney

#CardiologyResidents


πŸ«€ Cardiology Content


#CardiologyCases

#ECGInterpretation

#EchoTraining

#CardiacCathLab

#CMRImaging

#EPTracings

#NuclearCardiology

#HeartFailureCare

#ArrhythmiaTraining

#InterventionalCardiology


πŸ‡΅πŸ‡° Pakistan & Hospitals


#NICVDKarachi

#AFICRawalpindi

#PICLahore

#RICRawalpindi

#FICFaisalabad

#MultanCardiology

#TabbaHeartInstitute

#AgaKhanHospital

#ShifaInternational

#RehmanMedicalInstitute

#DowUniversityHospital

#CPSPPakistan

#PakMedStudents

#PakDoctors

#CardiologyPakistan


πŸ’» General Reach Hashtags


#MedicalEducation

#DoctorLife

#PostgraduateTraining

#MedStudentsPakistan

#CardiologyLearning

#ClinicalSkills

#MedicalExams2025

#OnlineMedicalLearning



---


πŸ’‘ Example Meta Description for Blog


> “Comprehensive guide for FCPS Cardiology TOACS preparation — includes ECG, Echocardiography, Cath Lab, CMR, CT, CXR, EP Tracings, and Nuclear Scans with commonly asked questions and answers. Perfect for FCPS Part 2 candidates in Pakistan from NICVD, AFIC, PIC, RIC, FIC, and other top cardiology training centers.”


---

Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...